Trials / Completed
CompletedNCT01118780
A Study of Duloxetine in Elderly Generalized Anxiety Disorder
Duloxetine Versus Placebo in the Treatment of Elderly Patients With Generalized Anxiety Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 291 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety and efficacy of duloxetine versus placebo in elderly patients suffering from generalized anxiety disorder (GAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Administered by mouth, daily for 10 weeks |
| DRUG | Placebo | Administered by mouth, daily for 10 weeks |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2010-05-07
- Last updated
- 2013-09-02
- Results posted
- 2013-09-02
Locations
25 sites across 9 countries: United States, Argentina, Austria, Canada, Germany, Mexico, Poland, Puerto Rico, United Kingdom
Source: ClinicalTrials.gov record NCT01118780. Inclusion in this directory is not an endorsement.